Shingles, or herpes zoster, is an infectious disease caused by the reactivation of the varicella-zoster virus, which also causes chickenpox. The disease is characterized by acute skin lesions in the form of painful vesicular eruptions limited to one or more dermatomes, and may also be accompanied by a level of pain known as postherpetic neuralgia. The main reason for the activation of the virus is a decrease in immune protection, which occurs, for example, in people over 50 years of age and in conditions of chronic stress or immunosuppression. Shingles usually develops in people who have already had chickenpox and can have serious complications, including neurological disorders.
History of the disease and interesting historical facts
Shingles has been known since ancient times. Similar symptoms are mentioned in the Corpus Hippocraticum, which suggests that the disease was already known in antiquity. In the Middle Ages, doctors described shingles as a malignant disease that could lead to death. With the discovery of the varicella-zoster virus in the mid-20th century, it became clear that the disease is associated with the reactivation of this virus. Interestingly, in Japanese culture, there was a tradition of associating shingles with weather changes, since the appearance of rashes was often observed during periods of abrupt climate change. In the modern world, the emphasis is shifting to studying the etiology and pathogenesis of the disease, which allows for more effective development of strategies for its prevention and treatment.
Epidemiology
Epidemiological studies of shingles indicate its prevalence, especially among the elderly. According to the World Health Organization, the incidence is approximately 3.2 cases per 1,000 people per year, and in people over 60 years of age, this figure may increase to 10 cases per 1,000 people. According to studies, in populations over 85 years of age, the probability of developing the disease reaches 50%. In addition, men are more susceptible to the disease than women, which may be due to differences in the immune response. Long-term studies show that the risk of developing shingles may increase 2-3 times in people who suffer from chronic diseases such as diabetes or cancer.
Genetic predisposition to this disease
Genetic susceptibility to shingles is being studied within the context of infectious disease genetics. Some researchers believe that there are certain mutations in genes involved in the immune response that may increase the risk of reactivation of the Gardenia virus. The genes most studied are those involved in the production of cytokines and macrophages, such as IL-6 and IL-10. Studies have shown that variations in these genes may lead to an abnormal immune response, which in turn contributes to the reactivation of the virus. A number of other genes, such as HLA-B and HLA-C, have also been identified as potentially involved in the development of the disease. These findings highlight the importance of further research to assess the impact of genetic susceptibility on the risk of the disease.
Risk factors for the development of this disease
There are several risk factors that contribute to the development of shingles. These include:
- Immunodeficiency states: Deficiency of cellular immunity caused by HIV, cancer, or immunosuppressive therapy.
- Age: The risk of the disease increases significantly after age 50, especially among people over 60.
- Stress: Psychological and physical stress can contribute to the reactivation of the virus.
- Trauma: The presence of trauma or surgery in the area of innervation can also contribute to the development of the disease.
- Other medical conditions: Having chronic medical conditions such as diabetes may increase your risk.
These factors highlight the importance of early recognition and adequate treatment of individuals at increased risk.
Diagnosis of this disease
Diagnosis of shingles is based on clinical examination and laboratory tests. The main symptoms are:
- Painful rashes located along the course of nerves;
- Vesicles filled with serous or hemorrhagic contents;
- Paraesthesia and burning in the affected area.
Laboratory investigations may include PCR to detect the virus in vesicular fluids. Radiological examinations such as MRI may be required to evaluate the nervous system if neurological complications are suspected. Differential diagnosis includes exclusion of other dermatoses such as contact dermatitis or herpes. Follow-up investigations include antibody testing and additional evaluation of the immune system.
Treatment
Treatment of shingles includes both symptomatic and antiviral therapy. The main treatment areas are:
- General treatment: Provide rest, take into account stress levels.
- Pharmacological treatment: Use of antiviral drugs such as acyclovir and valacyclovir.
- Surgical treatment: In rare cases, surgery may be required to correct neurological complications.
- Other treatments: Use of analgesics and anti-inflammatory drugs to relieve symptoms.
Physiotherapy and psychotherapy methods can also be used in complex treatment.
List of medications used to treat this disease
The following medications are used to treat shingles:
- Acyclovir;
- Valaciclovir;
- Famciclovir;
- Neopoietin (for the treatment of postherpetic neuralgia);
- Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief.
The effectiveness of each group of drugs is high, but they should be prescribed by a doctor depending on the individual characteristics of the patient.
Disease monitoring
Monitoring of shingles involves regular observation of the patient's condition, assessment of the effectiveness of treatment and possible complications. The main control stages include:
- Regular examinations by a dermatologist and neurologist;
- Assessing pain levels and other symptoms;
- Monitoring the state of the immune system.
The prognosis with early treatment is usually good, but complications such as postherpetic neuralgia are possible, which can persist for months or years after the acute phases of the disease have resolved.
Age-related features of the disease
Shingles manifests itself differently in different age groups. In children, the disease is usually milder and has fewer complications. In older people, the risk of developing serious complications, including postherpetic neuralgia, is significantly increased. In younger people, shingles is usually milder, but is associated with high levels of stress and exhaustion.
Questions and Answers
- What are the symptoms of shingles? Symptoms include painful vesicular rashes limited to dermatomes, burning and itching on the affected skin.
- What is the prognosis for shingles? The prognosis is usually good, but complications such as postherpetic neuralgia may occur.
- Which treatments are most effective? Antiviral drugs such as acyclovir are considered the most effective in treatment.
- Can shingles come back? Yes, it is possible for the virus to reactivate, but most often the disease occurs once in a lifetime.
- What are the risk factors for developing the disease? Risk factors include age over 50, chronic diseases and stress.
This article contains information aimed at raising awareness about the disease and external factors that can trigger it. It is always recommended to consult a specialist for long-term medical care.
